Medicine Range - S

Our range of generic and branded medicines and medical devices includes prescription medicines used in primary and secondary care and covers a broad range of therapeutic areas.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Salbutamol

Teva markets Salbutamol. The Summary of Product Characteristics, along with the Patient Information Leaflet for Salbutamol from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (6)
Available as
  • Inhaler
  • Nebuliser Solution

Sertraline

Teva markets Sertraline. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sertraline from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (2)
Available as
  • Film-coated Tablets

Sevoflurane

Teva markets Sevoflurane. The Summary of Product Characteristics, along with the Patient Information Leaflet (PIL) for Sevoflurane from Teva can be downloaded below, along with other information such as Frequently Asked Questions (FAQs) where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Inhalation Vapour

Sildenafil

Teva markets Sildenafil. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sildenafil from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (17)
Available as
  • Film-coated Tablets

Simeticone

Teva markets products containing Simeticone. The Summary of Product Characteristics, along with the Patient Information Leaflet for products containing Simeticone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (4)
Available as
  • Chewable Tablets
  • Oral Liquid
  • Soft Capsules

Simvastatin

Teva markets Simvastatin. The Summary of Product Characteristics, along with the Patient Information Leaflet for Simvastatin from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (2)
Available as
  • Film-coated Tablets

Sodium Alginate

Teva markets Sodium Alginate containing medicine(s). The Summary of Product Characteristics (SmPC) and the Patient Information Leaflet for Sodium Alginate containing medicines from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) you can contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone 0207 540 7117.

View all medicines (2)
Available as
  • Liquid

Sodium Bicarbonate

Teva markets Sodium Bicarbonate. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sodium Bicarbonate from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (4)
Available as
  • Capsules
  • Chewable Tablets
  • Granules for Solution

Sodium Carbonate

Teva markets products containing Sodium Carbonate. The Summary of Product Characteristics, along with the Patient Information Leaflet for products containing Sodium Carbonate from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Granules for Solution

Sodium Chloride

Teva markets Sodium Chloride. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sodium Chloride from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Nebuliser Solution

Sodium Citrate

Teva markets products containing Sodium Citrate. The Summary of Product Characteristics, along with the Patient Information Leaflet for products containing Sodium Citrate from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Granules for Solution

Solifenacin

Teva markets solifenacin. The Summary of Product Characteristics, along with the Patient Information Leaflet for solifenacin from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (2)
Available as
  • Film-coated Tablets

Sorafenib

Teva markets Sorafenib. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sorafenib from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Film-coated Tablets

Sotalol

Teva markets Sotalol. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sotalol from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (1)
Available as
  • Tablets

Spironolactone

Teva markets Spironolactone. The Summary of Product Characteristics, along with the Patient Information Leaflet for Spironolactone from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (3)
Available as
  • Tablets

Sumatriptan

Teva markets Sumatriptan. The Summary of Product Characteristics, along with the Patient Information Leaflet for Sumatriptan from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

View all medicines (3)
Available as
  • Film-coated Tablets

Medicines showing this symbol are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get through the Yellow Card Scheme.

Date of preparation: August 2021
Reference: COB-GB-NP-00077

Date of preparation: August 2021
Reference: COB-GB-NP-00078